by Colfar | junio 26, 2019 10:40 am
Farmacovigilancia. Denosumab. Riesgo de Osteonecrosis mandibularSource URL: https://colfarsfe.org.ar/2019/06/26/denosumab-riesgo-de-osteonecrosis-mandibular-aemps/
Copyright ©2024 Colegio de Farmacéuticos de Santa Fe 1 Circ. unless otherwise noted.